Advertisement

News

Make CHEST Physician® a trusted source
  • While still elevated, early 2026 data show US influenza A cases stabilizing or decreasing

    While still elevated, early 2026 data show US influenza A cases stabilizing or decreasing

    Infectious disease expert Frederick G. Hayden, MD, said timely use of antivirals for prophylaxis and treatment can minimize the impact of this flu season, which has seen a significant mismatch between vaccines and the circulating strain.


  • From chalkboards to chatbots: The emerging landscape of AI in medical education

    From chalkboards to chatbots: The emerging landscape of AI in medical education

    Professors Deepak R. Pradhan, MD, MHPE, FCCP, and Richard M. Schwartzstein, MD, FCCP, discuss the opportunities—and potential pitfalls—of the increasing adoption of artificial intelligence.


  • GLP-1RAs may trigger chronic cough for some patients with diabetes

    GLP-1RAs may trigger chronic cough for some patients with diabetes

    Surprisingly, the association between GLP-1 medications and chronic cough was stronger in patients without an existing diagnosis of gastroesophageal reflux disease.



  • Optimal synergy: Coupling smart wearable devices, sensors with AI algorithms

    Optimal synergy: Coupling smart wearable devices, sensors with AI algorithms

    Coupling noninvasive wearable devices with AI-enabled data analytics helps to address two key challenges: health care access and improvement of patient-centric care.


  • De-escalating antibiotics proves safe for patients with community-onset sepsis

    De-escalating antibiotics proves safe for patients with community-onset sepsis

    Ashwin B. Gupta, MD, addresses lingering clinician hesitancy surrounding the de-escalation of antibiotics for adults hospitalized for community-onset sepsis.


  • GLP-1RAs may reduce risk of asthma exacerbations for adolescents with obesity

    GLP-1RAs may reduce risk of asthma exacerbations for adolescents with obesity

    Pulmonologist Farrukh Abbas, MD, said this observational study generates a hypothesis about the anti-inflammatory benefits of GLP1-RA medications in patients with asthma and obesity that needs to be confirmed in trials.


  • 2026 GOLD report provides key updates on COPD exacerbations, case finding

    2026 GOLD report provides key updates on COPD exacerbations, case finding

    Gerard J. Criner, MD, FCCP, a member of the GOLD Science Committee, said the latest insights aim to improve patient outcomes and bring awareness to treating COPD exacerbations.


  • AI-enabled approaches poised to transform diagnosis, management of lung diseases

    AI-enabled approaches poised to transform diagnosis, management of lung diseases

    Experts explore how AI-based tools can be used to bridge diagnostic challenges and address unmet needs in chronic respiratory disease care.



  • Patients with COPD, bronchiectasis experience sex-based disparities in care

    Patients with COPD, bronchiectasis experience sex-based disparities in care

    Radmila Choate, PhD, MPH, and her team sought to capture “lived experiences in a way that helps clinicians recognize patterns that differ for women and men and adapt care more thoughtfully.”


  • Mucus plug gene expression could identify new COPD targets

    Mucus plug gene expression could identify new COPD targets

    Recent research has identified distinct gene clusters that may underly the clinical heterogeneity of mucus pathology and inform further studies, investigator Ehab Billatos, MD, said.